Patent · US Active

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

US8969552B2 · kind B2 · utility

1Cited by

1References

25Claims

0Family size

Assignee

Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

Karla Drescher · Ludwigshafen, DE
Andreas Haupt · Ludwigshafen, DE
Liliane Unger · Ludwigshafen, DE
Sean Colm Turner · Ludwigshafen, DE
Wilfried Braje · Ludwigshafen, DE
Roland Grandel · Dossenheim, DE
Christophe Henry · Munich, DE

Key dates

Filing date	Oct 14, 2005
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Mar 28, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to aromatic compounds of the formula Iwherein Ar is phenyl or an aromatic 5- or 6-membered C-bound heteroaromatic radical, wherein Ar may carry 1 radical Ra and wherein Ar may also carry 1 or 2 radicals Rb; The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.